CRISM

COVID-19, Substance Use, and Safer Supply: Clinical guidance to reduce risk of infection and overdose
2020-04-08 16:00 - 17:00 (America/New_York)
This webinar will provide prescribers, pharmacists, and other allied health care workers background on mitigating risks through safer supply.
The COVID-19 pandemic and ongoing overdose crisis are creating compounded risks for people who use substances, including the risk for overdose and other harms related to an increasingly toxic illicit drug supply, the risk of infection and spread of infection among those with underlying health conditions and who face social marginalization, and risks due to withdrawal for those who must self-isolate or quarantine to prevent the onward spread of COVID-19.
The BC Centre on Substance Use has developed clinical guidance to health care providers to support patients to mitigate these competing priorities and compounded risks and enable social distancing and self-isolation measures, where possible, to reduce and prevent the spread of COVID-19. This guidance is not intended for treatment of substance use disorders but rather to support individuals with substance use disorders to self-isolate or social distance and avoid risk to themselves or others.
Presenters:

Guy Felicella, Peer Clinical Advisor, BC Overdose Emergency Response Centre (OERC)
Cheyenne Johnson, Co-Interim Executive Director, BC Centre on Substance Use (BCCSU)
Dr. Andrea Sereda, Family Physician, London InterCommunity Health Centre (LIHC)
Matthew Bonn, Program Coordinator, Canadian Association of People Who Use Drugs (CAPUD)

Rainbow Health Ontario 2020 Conference
2020-04-21 08:00 - 2020-04-23 17:00 | in Niagara Falls, Ontario

Stimulus connect #1 : What’s New in Harm Reduction Supply Distribution
2020-04-22 14:00 - 2020-04-24 17:30
The first Stimulus Connect What’s New in Harm Reduction Supply Distribution is an opportunity to hear from folks at the Manitoba Harm Reduction Network, HIV West Yellowhead, AIDS Committee of Newfoundland and Labrador and Blood Ties Four Directions. Join others into the conversation and discuss this new COVID-19 reality.
We expect this Stimulus Connect to be 1.5 hours and we will be using Zoom videoconferencing. The Stimulus Connect is this Friday at: 11 am Pacific, Noon Mountain, 1 pm Central, 2 pm Eastern, 3 pm Atlantic and 3:30 in Newfoundland.

Public Health 2020
2020-04-28 08:00 - 2020-04-30 14:00 | Centre des congrès RBC, 375 York Ave, Winnipeg, Manitoba, R3C3J3, Canada

CAHR 2020
2020-04-30 08:00 - 2020-05-03 17:00 | Centre des congrès de Québec, 1000, boul. René-Lévesque Est, Québec, Québec, G1R 5T8, Canada
The 29th Annual Canadian Conference on HIV/AIDS Research is the premier gathering in Canada for those working in all disciplines of HIV/AIDS research, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic.

Virtual discussion on safe supply in times of COVID-19
2020-05-07 15:00 - 17:00
This virtual discussion will be the occasion to share and to learn about the advancements, challenges and opportunities around safe supply in times of COVID-19.
Objectives

Discuss the context of safe supply in Canada.
Identify challenges.
Identify the opportunities available to individuals, as well as to organizations and institutions working in the addictions and healthcare fields.
Provide avenues to promote the implementation of safe supply practises and measures.

Speakers

Dre Marie-Ève Goyer, Programme Cran, CIUSSS du Centre-Sud-de-l’Île-de-Montréal
Isabelle Fortier, Moms Stop The Harm
Alexandra de Kiewit, Canadian Association of People Who Use Drugs (CAPUD)
Jessica Quijano, Association québécoise pour la promotion de la santé des personnes utilisatrices de drogues (AQPSUD)
Animated by: Julie-Soleil Meeson et Jessica Turmel, Association des intervenants en dépendance du Québec (AIDQ)

The event will be simultaneously translated into English (in writing) by Sophie Wertheimer.
Register now before Mai 7 at 11 h (EST)

Stimulus Connect #2: COVID-19: Impacts on the Drug Market
2020-05-26 13:00 - 15:00
Stimulus Connect was envisioned by the Stimulus National Implementation and Planning (SNIP) Committee in response to the parallel public health emergencies of the toxic illegal drug market and Covid-19. Stimulus Connect is not just another webinar, it is an opportunity for Canadian stakeholders in harm reduction and drug policy to come together, learn and network on specific topics.
Canada’s drug markets have been dramatically impacted by the national and provincial Covid-19 policy changes. This Stimulus Connect will bring together key people to discuss the Canadian dark web, Canadian drug checking results and key information from Substance Use Experts. Following those speakers we are taking questions live from the Stimulus Connect participants.
Free to register

"Changing Practice, Changing Policy" BC Substance Use Conference 2020
2020-06-04 08:00 - 2020-06-06 17:00 | JW Marriott Parq Vancouver Hotel, 39 Smithe St, Vancouver, C.-B., V6B 0R3, Canada
Target audience: health care providers, researchers, people with lived and living experience, families impacted by substance use, policymakers, health authority partners, and community advocates
Register to attend the conference: https://events.eply.com/BCCSU2020

CALL FOR ABSTRACTS:
Are you interested in submitting an abstract? We are now accepting abstracts for the BC Substance Use Conference!
Deadline to submit: Feb 28 (Fri) | 0800 AM PST
Submit your abstract here: http://bit.ly/BCCSU2020abstract
Notices to be sent by early April. Note: please ensure that you read the conditions before submitting an abstract.

Invited Keynotes:
o Leo Beletsky. Professor of Law and Health Sciences and Faculty Director, Health in Justice Action Lab, Northwestern University School of Law, Boston.
o Eric Costen. Associate Assistant Deputy Minister, Controlled Substances and Cannabis Branch, Health Canada.
o Terry Lake. Former Minister of Health of British Columbia.
o Jane Philpott. MD, former Member of Parliament. She served in numerous cabinet positions from 2015 to 2019, including Minister of Health, Minister of Indigenous Services, President of the Treasury Board and Minister of Digital Government.

Rapid Access to Addiction Medicine and Withdrawal Options
2020-08-11 13:00 - 14:00
Date: August 11, 2020, 1 p.m. – 2 p.m., EST – Register now
Speaker:
Dr. Ginette Poulin, Clinical Lead, Canadian Research Initiative in Substance Misuse
This webinar will explore the impact of COVID-19 on access to addiction medicine and withdrawal options. More details to be released soon.
Please note that this webinar will be presented in English.

Overdose and COVID-19: Double Crisis and System Challenge
2020-09-17 16:30 - 17:30
You are invited to participate in the COVID-19 Network Webinar on Thursday, September 17 from 4:30 p.m. to 5:30 p.m. + ½ hours questions / answers.
Presenter: Michael Krausz, MD, PhD, University of British Columbia
Objectives:

Addressing the impact of the two health emergencies and the quality of our response
Start a conversation about the necessary reform of the healthcare system based on the first experiences of these crises
Reflecting on mental health and addiction care in Canada in light of current experiences

STIMULUS 2020: Drugs, policy and practise in Canada
2020-09-30 08:00 - 2020-10-02 17:00
Stimulus: Drugs, Policy and Practice in Canada’s work has changed. Like many others across Canada, the planning team responded to COVID-19 as best we could within this ever changing context. The Stimulus coordinator engaged in worked within the Canadian Drug Policy Coalition team to launch and manage COVID-19 Harm Reduction Resources. This webpage has grown to be a useful tool for Canadian harm reduction and drug policy stakeholders as they respond to both public health crises.
Stimulus 2020, the in person conference is not happening this autumn. A virtual Stimulus 2020 conference is a possibility and we are in early discussion about if and how it could happen.
Through the work of the Stimulus National Implementation and Planning (SNIP) Committee we have pivoted to include 2 new programming pieces:

Harm Reduction Happy Hour every Wednesday from 5 p.m. to 7 p.m. This group will be in English only. Harm Reduction Happy Hour is an opportunity for harm reductionists to check in with each other each week. The space is casual and our time together is an opportunity to connect with others. Here is the link for details: https://stimulusconference.ca/harm-reduction-happy-hour/
The first Stimulus Connect: Stimulus Connect is not just another webinar, it is an opportunity for Canadian stakeholders in harm reduction and drug policy to come together, learn and network on specific topics. The topics are gathered through a range of methods including from SNIP meetings, media, previous Stimulus Connects as well as Harm Reduction Happy Hour. For more details: https://stimulusconference.ca/stimulus-connect/

Feast Centre for Indigenous STBBI Research Virtual Launch
2020-10-14
invite you to join the virtual launch of the Feast Centre for Indigenous STBBI Research today, October 14, with a LIVE broadcast at noon and a rebroadcast at 7 PM. (EDT)
Register and watch at feastcentre.moonfruit.com or stream the live broadcast at the Centre’s Facebook page (facebook.com/thefeastcentre).

For more information, visit the Centre’s official website.

Decriminalization: beyond the buzzword
2020-10-14 13:00 - 15:00
Up to now, drug policies in Canada have failed to protect the health and human rights of people who use drugs. Criminalization puts, more than ever, people who use drugs at risk and contributes to their marginalization and oppression. As the country faces two major crises, establishing a public health and human rights approach to drugs is urgently needed to save lives.
In this webinar, four speakers will present different aspects and international models surrounding decriminalization of drug possession for personal use.
This is a free event. Translated simultaneously in both languages.
Click here to register.

Concurrent disorders: a syndemia to unravel. Scientific activity on November 11th 2020
2020-11-11 09:00 - 16:00
The Centre of Expertise and Collaboration in Concurrent Disorders of the RUISS of the University of Montreal invites you to its annual scientific activity under the theme Concurrent disorders : a syndemia to unravel.
Whether you are a public or community worker, manager, professor, student or researcher in the field of mental health and addiction, this activity is for you. It will be an opportunity to learn and reflect on the impact of concurrent disorders on access to care and the trajectory of those affected. Through presentations and discussions, we hope to demonstrate the relevance of the syndemic approach in transforming our care and service organizations.
Please note that this webinar will be presented in French.

Lancement virtuel : À la rencontre de la relation d'aide difficile
2020-11-16 12:00 - 13:00
Les Presses de l’Université Laval vous invitent au lancement virtuel du livre « À la rencontre de la relation d’aide difficile » sous la direction de Michel T. Giroux qui se tiendra le lundi 16 novembre à 12h sur la plateforme Zoom.
Le livre:
Le lecteur découvrira à la fois un exposé théorique fondamental en psychologie et des instruments pratiques destinés au professionnel déstabilisé qui souhaite voir clair en lui-même. Des notions capitales en éthique clinique présentent au professionnel des instruments intellectuels qui lui permettent de donner un sens à sa conduite. Les études de cas sur des relations d’aide difficiles montrent comment la dimension clinique, le droit et l’éthique peuvent être utilisés dans la réflexion du professionnel.
Les collaborateurs:

André Renaud: Psychologue et psychanalyste en pratique privée;
Michelle Boivin: Travailleuse sociale et coordonnatrice clinique à l’I.R.D.P.Q.;
Claude Maheux: Médecin retraité du CHU de Québec-Université Laval;
Anne-Marie Savard: Juriste et professeure à la Faculté de droit Université Laval;
Sylvain Auclair: Professeur de philosophie au Cégep de Sainte-Foy;
Marie-Ève Bouthillier: Éthicienne clinique à l’Unité d’éthique clinique de l’Hôpital de la Cité-de-la-Santé, Laval;
Suzanne Brissette: Médecin, chef du service de médecine des toxicomanies, CHUM;
Delphine Roigt: Chargée d’enseignement de clinique, Département de médecine familiale et d’urgence à la Faculté de médecine – Université de Montréal;
Bruno Hébert: professeur de philosophie à la retraite, artiste peintre et écrivain.

Inscrivez-vous gratuitement!

Élimination de l’hépatite C : soutenir la réponse canadienne pendant et après la COVID-19
2020-11-25 12:00 - 13:30
Webinaire en français organisé par CATIE en partenariat avec CanHepC portant sur les implications de la COVID-19 sur les efforts d’élimination et pour les personnes vivant avec le VHC. Avec la participation du Dre Marina Klein, du Dre Julie Bruneau et du Dr Brian Conway.

Webinar on the Guidance Documents on Substance Use and COVID-19
2021-02-05 13:00 - 14:00
Friday 5, 2021 – 1pm to 2pm EST
Calendar entry.
At the request of the Government of Canada, the Canadian Research Initiative in Substance Misuse (CRISM) developed 6 national guidance documents that address the urgent needs of people who use substances, as well as service providers and decision makers during the COVID-19 pandemic.
As part of a knowledge dissemination approach, Health Canada will be hosting a webinar, led by one of CRISM’s investigators Dr. Tara Elton-Marshall, to provide an overview of the 6 guidance documents as well as other rapid response projects related to substance use and COVID-19 such as the qualitative survey of the impact of COVID-19 on People with Living Experience of Drug Use.
Dr. Elton-Marshall is an Independent Scientist and a Co-Section Head of the Population Health and Community Transformation (PHACT) section in the Institute for Mental Health Policy Research (IMHPR) at CAMH, an Assistant Professor (status only) at the University of Toronto and an adjunct Associate Professor at Western University. She is a Co-PI on the Ontario Node of the Canadian Research Initiative in Substance Misuse (CRISM), a strategic initiative funded by CIHR. CRISM is a national network of researchers, service providers, policy makers and people with lived experience across Canada. The goal of CRISM is to conduct and translate evidence-based interventions for substance misuse to improve the health care system.
Please note, the guidance provided in the documents is subject to change as new information becomes available and the pandemic and public health responses evolve over time.
We invite you to extend this invitation to other stakeholders that you feel would benefit from this webinar. Please note that this webinar will be presented in English however a French webinar on the guidelines will be held at a later date in February 2021.
CRISM is available to present additional webinars on each of the 6 topic areas. If you are interested in additional webinars, you can indicate your interest by completing the survey found at: https://www.surveymonkey.com/r/7YD9N2K.
Webex Online Meeting Information

Go to https://canada.webex.com/canada/j.php?MTID=m73ed58de93e1517b962eaacfdd466f76 the day of the webinar
Enter your name and email address.
Enter the meeting password: [REDACTED]
Follow the instructions that appear on your screen

Teleconference dial-in (If not using web audio)

Toll Free 1-855-288-0982
Toll Free 2 1-855-244-8677
Access Code: 179 591 1771

Événement virtuel sur la crise des surdoses : Des données aux actions
2021-02-17 13:00 - 15:00
Programmation détaillée

Mise en contexte de la situation des surdoses au Québec
Qu’est-ce qui circule dans le marché illicite au Québec et ce que ces données nous révèlent ?
La pharmacothérapie de remplacement au Québec
Présentation de l’outil Reconnaître et agir de l’Équipe de soutien clinique et organisationnel en dépendance et itinérance

Public cible
Pour les professionnels du réseau de la santé et des services sociaux ainsi que du milieu communautaire.

Conférencièr.e.s

Thierry Lefrançois, Superviseur au Service d’analyse des drogues, Direction générale des opérations réglementaires et de l’application de la loi, Santé Canada
Dre Marie-Ève Goyer, Directrice scientifique, Équipe de soutien clinique et organisationnel en dépendance et itinérance, IUD
Jérôme Benedetti, Assistant de recherche, Équipe de soutien clinique et organisationnel en dépendance et itinérance, IUD
Karine Hudon, Coordonnatrice, Équipe de soutien clinique et organisationnel en dépendance et itinérance, IUD

Une opportunité à saisir : Implanter un centre de prévention des surdoses

Les différents types de site de consommation, avec la participation de Richard Cloutier, DGSP, MSSS
Capsules vidéo: Portrait de 3 centres de prévention des surdoses du Québec
Boîte à outils pour soutenir l’implantation d’un centre de prévention des surdoses au Québec de l’Équipe de soutien clinique et organisationnel en dépendance et itinérance

Inscription gratuite mais obligatoire.

Stimulus Connect 10: Impact of the Pandemic on People Who Use Drugs
2021-02-18 13:00 - 15:00
10am – noon Pacific 11am – 1pm Mountain 12-2pm Central 1-3pm Eastern 2-4pm Atlantic 2:30-4:30pm Newfoundland & Labrador
Public health in Canada responded dramatically to the COVID-19 crisis and not the overdose crisis. Join us for the Impact of the Pandemic on People Who Use Drugs: Part 1 as we connect.

Webinar on the Guidance Documents on Substance Use and COVID-19
2021-02-24 12:00 - 13:00
At the request of the Government of Canada, the Canadian Research Initiative in Substance Misuse (CRISM) developed 6 national guidance documents that address the urgent needs of people who use substances, as well as service providers and decision makers during the COVID-19 pandemic.
Health Canada and CRISM will be hosting a webinar, led by Dr. Julie Bruneau, to provide an overview of the 6 guidance documents as well as other rapid response projects related to substance use and COVID-19.
The webinar will be held in French.
Register now!

Virtual Harm Reduction Symposium - Time's Up
2021-02-24 12:00 - 15:30
The Harm Reduction Symposium will bring together many stakeholders to raise awareness, educate, and enhance harm reduction collaboration.

CALL TO ACTION:
As a community, it is our responsibility to improve the lives of those impacted by problematic substance use. To achieve this, we need to reduce stigma, increase community collaboration, and influence systematic changes.

Impact of Drug Use in Canada:
The opioid crisis continues to claim the lives of Canadians. 17,602 apparent opioid-related deaths occurred between January 2016 and June 2020.
1,628 apparent opioid toxicity deaths occurred between April and June 2020, representing the highest quarterly count since national surveillance began in 2016.

In Canada, more than 12 deaths per day are due to the opioid crisis.
New Brunswick is reported to have the second highest prevalence of injection drug use in the country, second only to British Columbia. A large spike in overdose deaths has been observed as the COVID-19 pandemic has evolved and an increase in deaths among People Who Use Drugs (PWUD) has been felt across the country. This was also noted by the Saint John Police Force in mid-October. The warning was extended to advocacy groups in southern New Brunswick following several months of observation during the pandemic. In general, PWUD have been more vulnerable during the COVID-19 pandemic, due to poor health literacy and stigma and discrimination. In this setting there have been calls for decriminalization and increased access to safe supply.
It is time to encourage community capacity building to address these complex issues. The Harm Reduction Symposium will provide a platform to discuss innovative and sustainable approaches.
The 3rd annual Harm Reduction Symposium will bring together many stakeholders to raise awareness, educate, and enhance harm reduction collaboration.

French Language iOAT Webinar - Addiction and Mental health Ontario
2021-03-10 13:00 - 14:00
Injectable opioid agonist treatment (iOAT) is a safe, life-saving, and cost-effective treatment option for individuals with severe opioid dependence. It is also virtually unavailable in Ontario. The need for iOAT has never been greater given an opioid crisis that has become the most enduring public health emergency in recent Canadian history and further fueled by the COVID-19 pandemic.
Please join Addictions and Mental Health Ontario and presenters Brian Rush and April Furlong on March 10th, to discuss AMHO’s Health Canada funded project exploring the need for prescription diacetylmorphine in Ontario.
The French language webinar will take place from 1-2 pm, please register here: https://us02web.zoom.us/webinar/register/WN_MIr-OBl_SPyDacfdjs1tsg.

Atlantic Indigenous Health Conference 2021
2021-03-23 - 2021-03-25
The three day event, presented by the Atlantic Policy Congress of First Nations Chiefs Secretariat, will feature speakers from across Canada discussing the theme Walking Together Through a Health Crisis and also include the Honouring Our People Awards. While this free event is open to the public, please note that the content will be tailored to those in the Atlantic region and the event will take place in Atlantic Standard Time (AST).
Register Now!

VIRTUAL EVENT: SAFER SUPPLY
2021-03-23 13:00 - 17:00
Detailed program
Presentation of the Guide d’usage optimal – Méthadone et buprénorphine de l’INESSS
Presentation of the work conducted by the Équipe de soutien clinique et organisationnel en dépendance et itinérance on the use of once-daily slow-release morphine (MLLU) in OAT in Quebec.
Interdisciplinary Panel on Safer Supply and Use of the MLLU
Canadian Expert Panel – Case Studies

Target audience
For health and social services professionals

Speakers
Coming soon

Practical information
Registration is free but mandatory.

Stimulus Connect 11: Impact of the Pandemic on People Who Use Drugs
2021-03-24 13:00 - 15:00
Public health in Canada responded dramatically to the COVID-19 crisis and not the overdose crisis. Join us for the Impact of the Pandemic on People Who Use Drugs: Part 2 as we connect.

6e Colloque international francophone sur le traitement de la dépendance aux opioïdes
2021-03-25 09:00 - 11:00
L’Institut universitaire sur les dépendances du Centre intégré universitaire de santé et de services sociaux du Centre-Sud–de-l’Île-de-Montréal organise présentement la 6e édition du colloque international TDO (traitement de la dépendance aux opioïdes). Le colloque TDO6 a une grande portée dans toute la francophonie ; en Europe, en Afrique et ici au Canada.

Pour cette édition, le thème est  Dialogues entre science et savoirs expérientiels : L’implication des usagers et des pairs dans le traitement du trouble lié à l’usage d’opioïdes, sur fond de crise en Amérique du Nord.

Le prochain webinaire est prévu pour le 25 mars 2021 (9 h à 11 h HNE) sous le thème Par et pour ; la participation des experts concernés dans les soins, la planification et l’organisation des services.
Un premier webinaire a déjà eu lieu le 3 février dernier (disponible en rattrapage sur le site Web du colloque).

Commission on Narcotic Drugs
2021-04-12 - 2021-04-16
The Commission on Narcotic Drugs (CND) is the body mandated to develop drug policy at the global level and is the governing body of UNODC. The Commission will take place next week, from 12 to 16 April 2021 and, because of the pandemic, all commission proceedings will be available to watch on a live webcast. (Central European Time)
To listen to the live proceedings of the Commission, please visit the webcast page. General information and documentation on the 64th CND is available here.

Variations temporelles de l’injection de drogues et association avec le risque d’infection par le virus de l’hépatite C
2021-04-13 12:30 - 13:30
La majorité des personnes utilisatrices de drogues par injection (PUDI) contracteront le virus de l’hépatite C (VHC), les mettant à risque accru de complications hépatiques graves et parfois mortelles. Les comportements les plus risqués pour l’acquisition du VHC incluent le partage de matériel d’injection et l’injection à haute fréquence. Un facteur jusqu’ici négligé dans l’évaluation du risque d’infection par le VHC est l’aspect dynamique de l’injection, c.-à-d. la manière dont elle varie dans le temps, incluant l’effet des périodes sans injection et celui des changements dans la fréquence d’injection. On reconnaît également l’effet délétère que l’instabilité résidentielle peut avoir sur le risque d’infection par le VHC, bien que les mécanismes sous-jacents soient mal compris.
Cette thèse s’intéresse à l’effet des variations temporelles de l’injection sur le risque de VHC, et à la manière dont la fréquence d’injection évolue en concomitance avec les conditions résidentielles dans le temps, afin d’aider au développement de nouvelles stratégies de prévention du VHC. Collectivement, les résultats qui seront présentés ont de nombreuses implications en termes de prévention du VHC.
Conférencier:
Emmanuel Fortier, MD, PhD (cand.)
Emmanuel Fortier a fait ses études de médecine à l’Université de Montréal et a fait des stages en médecine et en psychiatrie des toxicomanies. Durant ses études de médecine, il a entrepris un MSc et un PhD dans l’équipe de Dre Julie Bruneau, en codirection avec Prof Jason Grebely du Kirby Institute en Australie.
Emmanuel est maintenant résident en psychiatrie à l’Université d’Ottawa. Il a déposé sa thèse de doctorat et il vient nous présenter ses travaux.
Inscrivez-vous gratuitement !

Journée de la recherche du DMFMU et du Réseau de recherche en soins primaires de l’UdeM (RRSPUM)
2021-04-14 08:00 - 16:45

Drug Use During Covid: A Harm Reduction Conversation
2021-04-17 13:00 - 14:30
Join the U.S.-based People of Color Psychedelic Collective for a Panel Discussion about harm reduction during Covid.
Participation is free!
For more information : http://bit.ly/pocharmredux
